Who owns Revelation Biosciences Inc?
- Ticker: REVB
- CUSIP Number: 76135l705
Tip: Access positions for across all investors
Analyze quarterly positions in Revelation Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revelation Biosciences stock
Who bought or sold Revelation Biosciences Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sabby Management | 606k | $484k | 193% | Dec 2025 |
|
| Armistice Capital | 80k | $114k | 100% | Sep 2025 |
|
| Vanguard Group | 53k | $42k | 100% | Dec 2025 |
|
| Geode Capital Management | 34k | $27k | 100% | Dec 2025 |
|
| Northern Trust | 22k | $18k | 100% | Dec 2025 |
|
| Hrt Financial | 15k | $12k | 100% | Dec 2025 |
|
| XTX Topco | 11k | $9.1k | 100% | Dec 2025 |
|
| UBS Group | 724.00 | $578.982800 | 36100% | Dec 2025 |
|
| Bnp Paribas Investment Partners | 38.00 | $0 | 100% | Dec 2025 |
|
| Danske Bank A/s | 1.00 | $1.000000 | 0% | Dec 2025 |
|
Who sold out of Revelation Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Sep 2025 | 77k | $110k |
| Jane Street | Sep 2025 | 15k | $21k |
| Tower Research Capital | Sep 2025 | 534.00 | $758.013000 |
| SBI Securities | Sep 2025 | 458.00 | $649.993600 |